GD-DOTA AS A GASTROINTESTINAL CONTRAST AGENT FOR GASTRIC-EMPTYING MEASUREMENTS WITH MRI

被引:50
作者
SCHWIZER, W
FRASER, R
MAECKE, H
SIEBOLD, K
FUNCK, R
FRIED, M
机构
[1] CHU VAUDOIS, PMU, DIV GASTROENTEROL, LAUSANNE, SWITZERLAND
[2] UNIV HOSP BASEL, DEPT NUCL MED, CH-4031 BASEL, SWITZERLAND
关键词
MAGNETIC RESONANCE IMAGING; MARKERS; GASTRIC EMPTYING;
D O I
10.1002/mrm.1910310407
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Current MR meal markers may interfere with gastric motility and secretion restricting the use of MRI in the measurement of gastric physiology. We therefore evaluated Gd-DOTA as a liquid phase marker, in vitro by determining dissociation, and adherence to the solids, and in vivo by simultaneous MRI (0.35 T scanner, multiple T1-weighted sections of the upper abdomen) and double indicator (perfusion marker PEG 4000, meal marker Tc-99m-DTPA) measurements of emptying and secretion, following ingestion of 500 ml 10% glucose. In vitro Gd-DOTA was stable at a pH > 2 with <2% dissociation at 24 h during incubation with HCl. Dissociation during incubation with HCI was linearly dependent on H+ concentration (0.77 < pH < 2.02). Less Gd-DOTA was absorbed onto the solid phase than Tc-99m-DTPA (25% of 36%). In vivo Gd-DOTA marked gastric contents provided strong positive contrast. Similar emptying curves were observed with both MRI and double-indicator techniques (r = 0.987, P < 0.001). Gd-DOTA has the potential to be a useful liquid phase contrast agent in MR studies on gastric function.
引用
收藏
页码:388 / 393
页数:6
相关论文
共 21 条
[1]   EXPERIMENTAL-STUDY OF DOTA-GADOLINIUM PHARMACOKINETICS AND PHARMACOLOGIC PROPERTIES [J].
ALLARD, M ;
DOUCET, D ;
KIEN, P ;
BONNEMAIN, B ;
CAILLE, JM .
INVESTIGATIVE RADIOLOGY, 1988, 23 :S271-S274
[2]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[3]   GD-DOTA - CHARACTERIZATION OF A NEW PARAMAGNETIC COMPLEX [J].
BOUSQUET, JC ;
SAINI, S ;
STARK, DD ;
HAHN, PF ;
NIGAM, M ;
WITTENBERG, J ;
FERRUCCI, JT .
RADIOLOGY, 1988, 166 (03) :693-698
[4]  
BRASCH RC, 1992, RADIOLOGY, V183, P1
[5]   PERFLUOROCTYLBROMIDE AS A GASTROINTESTINAL CONTRAST AGENT FOR MR IMAGING - USE WITH AND WITHOUT GLUCAGON [J].
BROWN, JJ ;
DUNCAN, JR ;
HEIKEN, JP ;
BALFE, DM ;
CORR, AP ;
MIROWITZ, SA ;
EILENBERG, SS ;
LEE, JKT .
RADIOLOGY, 1991, 181 (02) :455-460
[6]  
FORDTRAN JS, 1966, GASTROENTEROLOGY, V51, P1089
[7]   FAST MR-IMAGING - TECHNIQUES AND CLINICAL-APPLICATIONS [J].
HAACKE, EM ;
TKACH, JA .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1990, 155 (05) :951-964
[8]   1ST CLINICAL-TRIAL OF A NEW SUPERPARAMAGNETIC IRON-OXIDE FOR USE AS AN ORAL GASTROINTESTINAL CONTRAST AGENT IN MR IMAGING [J].
HAHN, PF ;
STARK, DD ;
LEWIS, JM ;
SAINI, S ;
ELIZONDO, G ;
WEISSLEDER, R ;
FRETZ, CJ ;
FERRUCCI, JT .
RADIOLOGY, 1990, 175 (03) :695-700
[9]   PHARMACOLOGY AND TOXICOLOGY OF RARE EARTH ELEMENTS [J].
HALEY, TJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1965, 54 (05) :663-+
[10]  
HOROWITZ M, 1989, GASTROINTESTINAL MOT, P73